Adherium, a digital health platform that focuses on improving medication adherence and patient outcomes, has launched the Hailie solution in the U.S., following its recent Food and Drug Administration (FDA) 510(k) over-the-counter clearance to enable sales direct to consumers. The Hailie solution is designed to help patients achieve better adherence by providing people who live with…
MilliporeSigma And InnoCore To Cooperate On New Drug Delivery Platform
MilliporeSigma and InnoCore Pharmaceuticals of Groningen, Netherlands, have entered into a global cooperation agreement to provide InnoCore’s proprietary SynBiosys biodegradable polymer platform. The drug delivery platform can be used to develop sustained release solutions for biologicals in injectable formulations. “Until now, formulating large biological active pharmaceutical ingredients such as proteins and large peptides into long-acting sustained release formulations has been difficult,…
Microsoft Delves Into Using Blockchain As Part Of A Process Flow
At the Adents Serialization Innovation Summit in Philadelphia, Tianna Umann, Microsoft software architect, gave a talk explaining that when used within an already existing end-to-end solution, blockchain can improve communication by storing and sharing product transaction and check-point status during the manufacturing process and along supply chain in a single, fixed ledger. Using a sequence…
Manufacturer Participation In Saleable Returns Verification And Master Data
The management of saleable returns in the U.S. pharma industry has traditionally fallen under the remit of wholesalers. Track-and-trace regulations in the form of the Drug Supply Chain Security Act (DSCSA) are forcing the industry to revisit that model. The key DSCSA milestone is November 2019, at which point wholesalers will be required to verify…
ObvioHealth Mobile App Aims To Transform Clinical Studies
Full-service CRO ObvioHealth has launched ClaimIt, a 100-percent online and mobile application for site-less clinical studies. The app removes costly physical site visits, allowing study participants to take part in healthcare research from their homes, improving convenience and compliance, while lowering drop-out rates. The company said that the application, targeting pharmaceutical, nutritional, observational, and other studies, also creates opportunities to leverage data captured from connected devices for clinical evaluation.…
Exosomics Siena Launches Exosome-Based Liquid Biopsy Technologies
Exosomics Siena S.p.A., a Lonza-backed diagnostics company, has launched its first proprietary liquid biopsy technologies, SeleCTEV DNA and SortEV RNA, for the selective isolation of tumor-derived nucleic acids from complex biofluids, such as plasma or serum. An Italian start-up company, Exosomics Siena develops exosome-based early-stage cancer screening and molecular diagnostic tests. In May 2017, Lonza invested in Exosomics Siena to help…
New Method Reveals How Well Cancer Drugs Hit Their Targets
Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets inside the body. It shows individual cancer cells in a tumor in real time, revealing which cells interact with the drug and which cells the drug fails to reach. In the future, the findings, published in Nature Communications, could…
A Seismic Shift For Inhalation Is Just The Beginning
For 35 years, I’ve watched new technology in drug delivery methods emerge from nearly every seat in the house, from R&D to project management to business development. Over the course of those years and job titles, this industry has remained steady in its approach of small, incremental changes. While progress can often feel like it…
The Potential For AI In Life Sciences
From accelerating scientific breakthroughs and spotting previously elusive patterns in unwieldy global data masses, to enabling greater drug personalization, the scope for artificial intelligence in life sciences seems unlimited. And, as other industries are experiencing, the technology already is tangible and something they must start planning for. Intelligent internet and content searches that adapt to…
Blockchain Audit Trail Comes To Pharma
At the recent INTERPHEX show in New York, Germany-based software developer eschbach GmbH introduced io.Equipment, a new digital equipment log book platform using blockchain technology designed to address the evolving regulations for tracking and tracing along the entire pharmaceutical drug supply chain. All equipment operations, such as cleaning, maintenance, breakdown, and manufacturing, can be recorded…